Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
0.9800
+0.00 (0.00%)
NASDAQ · Last Trade: Nov 12th, 4:10 AM EST
Detailed Quote
Previous Close
0.9800
Open
-
Bid
1.210
Ask
1.230
Day's Range
N/A - N/A
52 Week Range
0.9100 - 108.00
Volume
0
Market Cap
43.88M
PE Ratio (TTM)
-0.3379
EPS (TTM)
-2.9
Dividend & Yield
N/A (N/A)
1 Month Average Volume
529,563
Chart
About Salarius Pharmaceuticals, Inc. - Common Stock (SLRX)
Salarius Pharmaceuticals is a clinical-stage biotechnology company focused on developing innovative therapies for cancer patients. The company specializes in the research and development of novel drug candidates that target specific epigenetic mechanisms to combat various forms of cancer. By harnessing the potential of these targeted therapies, Salarius aims to improve treatment outcomes and minimize side effects for patients. The company's approach emphasizes precision medicine, with a commitment to addressing unmet medical needs in oncology through robust scientific innovation and clinical trials. Read More
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Looking for insights into the US markets in the middle of the day on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
